Global burden and trends of viral hepatitis among women of childbearing age from 1990 to 2021
The burden and trends of viral hepatitis in women of childbearing age (WCBA) are rarely quantified. This study aimed to assess the global, regional, and national incidence and prevalence rates among WCBA from 1990 to 2021. From 1990 to 2021, we retrieved data from the Global Burden of Diseases, Inju...
Saved in:
| Published in | Frontiers in microbiology Vol. 16; p. 1553129 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
Frontiers Media S.A
21.02.2025
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1664-302X 1664-302X |
| DOI | 10.3389/fmicb.2025.1553129 |
Cover
Loading…
| Abstract | The burden and trends of viral hepatitis in women of childbearing age (WCBA) are rarely quantified. This study aimed to assess the global, regional, and national incidence and prevalence rates among WCBA from 1990 to 2021.
From 1990 to 2021, we retrieved data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 on the incidence and prevalence of hepatitis A, B, C, and E for WCBA. Estimated annual percent change in the age-standardized incidence and prevalence rates were calculated to quantify the temporal trend.
In 2021, it was estimated that there were 42,266,708 new cases and 109,107,759 prevalent cases of viral hepatitis among WCBA globally. AHA had the highest incidence rate, while CHB had the highest prevalence rate globally. Notably, AHA and AHE were emerging in low-endemic regions. Generally, the burden of viral hepatitis decreased with higher SDI levels, except for AHA. Between 1990 and 2021, the global age-standardized incidence rate for viral hepatitis among WCBA decreased annually by -1.11% for acute hepatitis A (AHA), -1.24% for AHB, and -0.18% for AHC, -0.34% for AHE, with more significant reductions observed for chronic hepatitis B (CHB) and CHC at -1.33% and -0.29%, respectively. Furthermore, the burden of viral hepatitis continued to rise in lower-SDI regions, and the proportion of younger individuals affected increased as SDI decreased.
Although the incidence and prevalence rates of viral hepatitis have decreased in recent decades, notable regional and demographic disparities remain. These concerning trends are especially pronounced in low-SDI regions, making it essential to tackle the disparities in healthcare resource allocation for WCBA across areas with varying SDI levels. |
|---|---|
| AbstractList | The burden and trends of viral hepatitis in women of childbearing age (WCBA) are rarely quantified. This study aimed to assess the global, regional, and national incidence and prevalence rates among WCBA from 1990 to 2021.
From 1990 to 2021, we retrieved data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 on the incidence and prevalence of hepatitis A, B, C, and E for WCBA. Estimated annual percent change in the age-standardized incidence and prevalence rates were calculated to quantify the temporal trend.
In 2021, it was estimated that there were 42,266,708 new cases and 109,107,759 prevalent cases of viral hepatitis among WCBA globally. AHA had the highest incidence rate, while CHB had the highest prevalence rate globally. Notably, AHA and AHE were emerging in low-endemic regions. Generally, the burden of viral hepatitis decreased with higher SDI levels, except for AHA. Between 1990 and 2021, the global age-standardized incidence rate for viral hepatitis among WCBA decreased annually by -1.11% for acute hepatitis A (AHA), -1.24% for AHB, and -0.18% for AHC, -0.34% for AHE, with more significant reductions observed for chronic hepatitis B (CHB) and CHC at -1.33% and -0.29%, respectively. Furthermore, the burden of viral hepatitis continued to rise in lower-SDI regions, and the proportion of younger individuals affected increased as SDI decreased.
Although the incidence and prevalence rates of viral hepatitis have decreased in recent decades, notable regional and demographic disparities remain. These concerning trends are especially pronounced in low-SDI regions, making it essential to tackle the disparities in healthcare resource allocation for WCBA across areas with varying SDI levels. The burden and trends of viral hepatitis in women of childbearing age (WCBA) are rarely quantified. This study aimed to assess the global, regional, and national incidence and prevalence rates among WCBA from 1990 to 2021.BackgroundThe burden and trends of viral hepatitis in women of childbearing age (WCBA) are rarely quantified. This study aimed to assess the global, regional, and national incidence and prevalence rates among WCBA from 1990 to 2021.From 1990 to 2021, we retrieved data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 on the incidence and prevalence of hepatitis A, B, C, and E for WCBA. Estimated annual percent change in the age-standardized incidence and prevalence rates were calculated to quantify the temporal trend.MethodsFrom 1990 to 2021, we retrieved data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 on the incidence and prevalence of hepatitis A, B, C, and E for WCBA. Estimated annual percent change in the age-standardized incidence and prevalence rates were calculated to quantify the temporal trend.In 2021, it was estimated that there were 42,266,708 new cases and 109,107,759 prevalent cases of viral hepatitis among WCBA globally. AHA had the highest incidence rate, while CHB had the highest prevalence rate globally. Notably, AHA and AHE were emerging in low-endemic regions. Generally, the burden of viral hepatitis decreased with higher SDI levels, except for AHA. Between 1990 and 2021, the global age-standardized incidence rate for viral hepatitis among WCBA decreased annually by -1.11% for acute hepatitis A (AHA), -1.24% for AHB, and -0.18% for AHC, -0.34% for AHE, with more significant reductions observed for chronic hepatitis B (CHB) and CHC at -1.33% and -0.29%, respectively. Furthermore, the burden of viral hepatitis continued to rise in lower-SDI regions, and the proportion of younger individuals affected increased as SDI decreased.ResultsIn 2021, it was estimated that there were 42,266,708 new cases and 109,107,759 prevalent cases of viral hepatitis among WCBA globally. AHA had the highest incidence rate, while CHB had the highest prevalence rate globally. Notably, AHA and AHE were emerging in low-endemic regions. Generally, the burden of viral hepatitis decreased with higher SDI levels, except for AHA. Between 1990 and 2021, the global age-standardized incidence rate for viral hepatitis among WCBA decreased annually by -1.11% for acute hepatitis A (AHA), -1.24% for AHB, and -0.18% for AHC, -0.34% for AHE, with more significant reductions observed for chronic hepatitis B (CHB) and CHC at -1.33% and -0.29%, respectively. Furthermore, the burden of viral hepatitis continued to rise in lower-SDI regions, and the proportion of younger individuals affected increased as SDI decreased.Although the incidence and prevalence rates of viral hepatitis have decreased in recent decades, notable regional and demographic disparities remain. These concerning trends are especially pronounced in low-SDI regions, making it essential to tackle the disparities in healthcare resource allocation for WCBA across areas with varying SDI levels.ConclusionsAlthough the incidence and prevalence rates of viral hepatitis have decreased in recent decades, notable regional and demographic disparities remain. These concerning trends are especially pronounced in low-SDI regions, making it essential to tackle the disparities in healthcare resource allocation for WCBA across areas with varying SDI levels. BackgroundThe burden and trends of viral hepatitis in women of childbearing age (WCBA) are rarely quantified. This study aimed to assess the global, regional, and national incidence and prevalence rates among WCBA from 1990 to 2021.MethodsFrom 1990 to 2021, we retrieved data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 on the incidence and prevalence of hepatitis A, B, C, and E for WCBA. Estimated annual percent change in the age-standardized incidence and prevalence rates were calculated to quantify the temporal trend.ResultsIn 2021, it was estimated that there were 42,266,708 new cases and 109,107,759 prevalent cases of viral hepatitis among WCBA globally. AHA had the highest incidence rate, while CHB had the highest prevalence rate globally. Notably, AHA and AHE were emerging in low-endemic regions. Generally, the burden of viral hepatitis decreased with higher SDI levels, except for AHA. Between 1990 and 2021, the global age-standardized incidence rate for viral hepatitis among WCBA decreased annually by −1.11% for acute hepatitis A (AHA), −1.24% for AHB, and −0.18% for AHC, −0.34% for AHE, with more significant reductions observed for chronic hepatitis B (CHB) and CHC at −1.33% and −0.29%, respectively. Furthermore, the burden of viral hepatitis continued to rise in lower-SDI regions, and the proportion of younger individuals affected increased as SDI decreased.ConclusionsAlthough the incidence and prevalence rates of viral hepatitis have decreased in recent decades, notable regional and demographic disparities remain. These concerning trends are especially pronounced in low-SDI regions, making it essential to tackle the disparities in healthcare resource allocation for WCBA across areas with varying SDI levels. |
| Author | Huang, Lu Yang, Shaojie Li, Yubin Lin, Shengyuan Zhong, Lin |
| Author_xml | – sequence: 1 givenname: Shaojie surname: Yang fullname: Yang, Shaojie – sequence: 2 givenname: Lin surname: Zhong fullname: Zhong, Lin – sequence: 3 givenname: Lu surname: Huang fullname: Huang, Lu – sequence: 4 givenname: Shengyuan surname: Lin fullname: Lin, Shengyuan – sequence: 5 givenname: Yubin surname: Li fullname: Li, Yubin |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40061861$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkU9rVTEQxYNUbK39Ai4kSzfvmf83WUrRWii4UXAjYZI7eU259-aZ3Gfx25v21WIWk3Dmx5kw5zU5WcqChLzlbCuldR_SnGPYCib0lmstuXAvyBk3Rm0kEz9O_nufkovW7lg_ioleX5FTxZjh1vAz8vNqKgEmGg51xIXCMtK14jI2WhL9nWtv3eIe1rzmRmEuy47el7mTvR1v8zQGhJq7CjukqZaZcucYXQvtX-NvyMsEU8OLp_ucfP_86dvll83N16vry483myicWjejiVyopFzAaMFCVEkMoJhJGIcEPIGLMNpgJA7JKOc0G5V0MiQ56IFZeU6uj75jgTu_r3mG-scXyP5RKHXnoa45TuiTA-0UMiNcUAk0BCYtCmuZHoaQsHu9P3rta_l1wLb6ObeI0wQLlkPzkg_aWK247Oi7J_QQZhyfB_9bbwfEEYi1tFYxPSOc-YcY_WOM_iFG_xSj_Avd2I6E |
| Cites_doi | 10.1016/S0140-6736(24)00757-8 10.1016/j.amepre.2018.05.029 10.1080/01621459.1979.10481038 10.1056/NEJMoa1406011 10.1016/j.lana.2024.100843 10.1016/S2468-1253(16)30152-2 10.3390/vaccines12030288 10.1016/j.jhep.2017.08.034 10.1016/S0140-6736(14)61187-9 10.4254/wjh.v7.i22.2418 10.1016/S2468-1253(20)30307-1 10.1016/S0140-6736(24)00476-8 10.1099/0022-1317-73-6-1365 10.1038/s41575-020-0332-6 10.1016/j.jhep.2020.04.008 10.1016/S2214-109X(21)00304-1 10.1016/S2468-1253(17)30007-9 10.1111/liv.14836 10.1080/21645515.2017.1323158 10.1016/S2214-109X(17)30142-0 10.1016/j.jhep.2021.04.035 10.1007/978-981-13-6806-6_5 10.1016/S2214-109X(17)30298-X 10.1002/rmv.482 10.1111/jvh.12757 10.1111/1469-0691.12535 10.1016/S0140-6736(10)61931-9 10.1038/nrgastro.2012.187 10.1093/infdis/jiu834 10.3389/fpubh.2023.1044788 10.1016/j.onehlt.2020.100186 10.1186/s12916-023-03006-2 10.1016/S2468-1253(22)00124-8 10.1101/cshperspect.a021550 10.1016/S2468-1253(20)30359-9 10.1136/gutjnl-2023-330691 10.1016/S2214-109X(22)00046-8 10.1038/s41575-020-0296-6 10.1016/S2214-109X(24)00192-X 10.1101/cshperspect.a021410 10.1093/epirev/mxj012 10.1016/j.ijid.2021.02.040 10.1016/S2214-109X(23)00057-8 10.1007/s12560-018-9342-8 10.1016/S2468-1253(20)30373-3 10.1080/21645515.2015.1008870 10.1016/j.vaccine.2020.12.043 10.1016/j.cmet.2021.08.005 10.1016/j.eclinm.2023.102327 10.1038/s41575-020-00361-w 10.1016/j.jhep.2020.11.027 10.1016/S0140-6736(20)30977-6 10.2807/1560-7917.ES.2023.28.30.2200738 10.1371/journal.pone.0153804 10.1038/s41598-019-38853-8 10.1016/j.meegid.2017.10.023 10.1002/hep.25505 10.1016/j.jhep.2014.07.027 10.1038/nrgastro.2016.7 10.1017/S0950268823000225 10.1016/j.jhep.2018.12.001 10.1016/j.tmaid.2018.07.012 10.1016/j.ajog.2021.09.002 10.1038/emi.2017.107 10.5468/ogs.2013.56.6.368 10.1093/ofid/ofac492.1071 10.1016/S2214-109X(20)30257-6 10.1056/NEJMsr1912628 10.1007/s12072-024-10640-2 10.1016/S2214-109X(24)00290-0 10.1007/s12072-016-9745-2 10.1016/j.jhep.2019.11.004 10.4161/hv.20475 10.1007/s12072-021-10232-4 10.1016/j.vaccine.2011.10.028 10.1002/hep4.1264 10.1038/s41575-024-00956-7 10.1016/j.jhep.2017.03.021 10.1002/cld.887 10.1016/j.vaccine.2010.08.037 10.1097/QCO.0000000000000188 10.1097/AOG.0000000000005300 |
| ContentType | Journal Article |
| Copyright | Copyright © 2025 Yang, Zhong, Huang, Lin and Li. |
| Copyright_xml | – notice: Copyright © 2025 Yang, Zhong, Huang, Lin and Li. |
| DBID | AAYXX CITATION NPM 7X8 DOA |
| DOI | 10.3389/fmicb.2025.1553129 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1664-302X |
| ExternalDocumentID | oai_doaj_org_article_f9a594e0629b4fa5ab038e2880577bfe 40061861 10_3389_fmicb_2025_1553129 |
| Genre | Journal Article |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK ECGQY GROUPED_DOAJ GX1 HYE KQ8 M~E O5R O5S OK1 PGMZT RNS RPM IPNFZ M48 NPM RIG 7X8 |
| ID | FETCH-LOGICAL-c294t-d6c124f49bec8a8ac4f27a406fec7fa1fa9cad8b63e7f649950d4393bf3757083 |
| IEDL.DBID | DOA |
| ISSN | 1664-302X |
| IngestDate | Wed Aug 27 01:25:56 EDT 2025 Fri Jul 11 16:00:48 EDT 2025 Thu Apr 03 06:54:53 EDT 2025 Tue Jul 01 05:27:45 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | viral hepatitis Global Burden of Disease women of childbearing age age-standardized rate estimated annual percentage change |
| Language | English |
| License | Copyright © 2025 Yang, Zhong, Huang, Lin and Li. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c294t-d6c124f49bec8a8ac4f27a406fec7fa1fa9cad8b63e7f649950d4393bf3757083 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/f9a594e0629b4fa5ab038e2880577bfe |
| PMID | 40061861 |
| PQID | 3175685413 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_f9a594e0629b4fa5ab038e2880577bfe proquest_miscellaneous_3175685413 pubmed_primary_40061861 crossref_primary_10_3389_fmicb_2025_1553129 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2025-02-21 |
| PublicationDateYYYYMMDD | 2025-02-21 |
| PublicationDate_xml | – month: 02 year: 2025 text: 2025-02-21 day: 21 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in microbiology |
| PublicationTitleAlternate | Front Microbiol |
| PublicationYear | 2025 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Lampertico (B32) 2017; 67 Cleveland (B15) 1979; 74 Gower (B22) 2014; 61 Liu (B37) 2018; 57 Li (B35) 2015; 11 Medicine (B46) 2023; 21 Jacobsen (B26) 2010; 28 Kwo (B31) 2019 Shiha (B61) 2020; 72 Judd (B27) 2021; 6 (B1) 2023 Zheng (B83) 2018; 25 Schmutz (B58) 2019; 27 Bailey (B8) 2023; 151 Velandia-González (B71) 2021; 39 Terrault (B66) 2021; 18 Verma (B72) 2012; 8 Kushner (B30) 2021; 74 Akyildiz (B5) 2020; 14 Ciglenecki (B14) 2017; 2 Robertson (B55) 1992; 73 Thompson (B68) 2021; 9 Liu (B38) 2017; 5 Zeng (B81) 2021; 75 Aggarwal (B3) 2013; 10 Van Effelterre (B70) 2017; 13 Waked (B73) 2020; 382 Isakov (B25) 2021; 41 Cox (B16) 2020; 17 Harder (B23) 2011; 29 Marti (B45) 2024; 12 Tian (B69) 2016; 10 Zaman (B80) 2024; 12 Aggarwal (B4) 2015 Kushner (B29) 2018; 2 Stockdale (B63) 2017; 5 Al-Busafi (B6) 2024 Liu (B39) 2024; 36 Negro (B48) 2014; 4 Botheju (B10) 2019; 9 MacLachlan (B44) 2015; 5 Revill (B53) 2016; 13 Xiao (B79) 2024; 18 Dionne-Odom (B19) 2022; 226 Wang (B74) 2020; 396 Wang (B76) 2016; 11 Salama (B56) 2015; 7 Schumacher (B59) 2024; 403 Parellada (B50) 2022; 9 Abbasi (B2) 2023; 66 King (B28) 2018; 10 Cao (B11) 2021; 15 Bivegete (B9) 2023; 28 Pawlotsky (B51) 2014; 384 Rein (B52) 2012; 55 (B67) 2016; 1 Noubiap (B49) 2022; 10 Liang (B36) 2023; 11 Lernout (B34) 2014; 20 Chaabna (B12) 2021; 105 Degenhardt (B18) 2023; 11 Schillie (B57) 2018; 55 Liu (B40) 2019; 70 Sheena (B60) 2022; 7 Revill (B54) 2020; 17 Nartey (B47) 2024; 21 Wang (B75) 2021; 33 Dugan (B20) 2021; 6 Lu (B42) 2006; 16 Sridhar (B62) 2017; 6 Stockdale (B64) 2020; 73 Wasley (B77) 2006; 28 Lemon (B33) 2018; 68 Hughes (B24) 2011; 378 Liu (B41) 2023; 72 Tan (B65) 2021; 6 Cui (B17) 2020; 8 Ly (B43) 2015; 212 Cho (B13) 2013; 56 Bagulo (B7) 2020; 11 Zhang (B82) 2015; 372 (B78) 2024 Ferrari (B21) 2024; 403 |
| References_xml | – volume: 403 start-page: 2133 year: 2024 ident: B21 article-title: Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 publication-title: Lancet doi: 10.1016/S0140-6736(24)00757-8 – volume: 55 start-page: 633 year: 2018 ident: B57 article-title: Hepatitis C virus in women of childbearing age, pregnant women, and children publication-title: Am. J. Prev. Med. doi: 10.1016/j.amepre.2018.05.029 – volume: 74 start-page: 829 year: 1979 ident: B15 article-title: Robust locally weighted regression and smoothing scatterplots publication-title: J. Am. Stat. Assoc. doi: 10.1080/01621459.1979.10481038 – volume: 372 start-page: 914 year: 2015 ident: B82 article-title: Long-term efficacy of a hepatitis E vaccine publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1406011 – volume: 36 start-page: 100843 year: 2024 ident: B39 article-title: More expansive diagnosis and treatment are urgently needed to eliminate the global burden of HBV publication-title: Lancet Reg. Health Am. doi: 10.1016/j.lana.2024.100843 – volume: 1 start-page: 261 year: 2016 ident: B67 article-title: Hepatitis E: a neglected virus publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(16)30152-2 – year: 2024 ident: B6 article-title: Global perspectives on the hepatitis B vaccination: challenges, achievements, and the road to elimination by 2030 publication-title: Vaccines (Basel) doi: 10.3390/vaccines12030288 – volume: 68 start-page: 167 year: 2018 ident: B33 article-title: Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention publication-title: J. Hepatol. doi: 10.1016/j.jhep.2017.08.034 – volume: 384 start-page: 1729 year: 2014 ident: B51 article-title: Hepatitis E screening for blood donations: an urgent need? publication-title: Lancet doi: 10.1016/S0140-6736(14)61187-9 – volume: 7 start-page: 2418 year: 2015 ident: B56 article-title: Effectiveness of hepatitis B virus vaccination program in Egypt: multicenter national project publication-title: World J. Hepatol. doi: 10.4254/wjh.v7.i22.2418 – volume: 6 start-page: 106 year: 2021 ident: B65 article-title: Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(20)30307-1 – volume: 403 start-page: 1989 year: 2024 ident: B59 article-title: Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950and#x2013;2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 publication-title: Lancet doi: 10.1016/S0140-6736(24)00476-8 – volume: 73 start-page: 1365 year: 1992 ident: B55 article-title: Genetic relatedness of hepatitis A virus strains recovered from different geographical regions publication-title: J. General Virol. doi: 10.1099/0022-1317-73-6-1365 – volume: 17 start-page: 533 year: 2020 ident: B16 article-title: Progress toward elimination goals for viral hepatitis publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-020-0332-6 – volume: 73 start-page: 523 year: 2020 ident: B64 article-title: The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis publication-title: J. Hepatol. doi: 10.1016/j.jhep.2020.04.008 – volume: 9 start-page: e1600 year: 2021 ident: B68 article-title: Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study publication-title: Lancet Global Health doi: 10.1016/S2214-109X(21)00304-1 – volume: 2 start-page: 154 year: 2017 ident: B14 article-title: Hepatitis E: urgent action needed publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(17)30007-9 – volume: 41 start-page: 50 year: 2021 ident: B25 article-title: Is elimination of hepatitis C virus realistic by 2030: Eastern Europe publication-title: Liver Int. doi: 10.1111/liv.14836 – volume: 13 start-page: 1942 year: 2017 ident: B70 article-title: Modeling the hepatitis A epidemiological transition in Brazil and Mexico publication-title: Hum. Vacc. Immunotherap. doi: 10.1080/21645515.2017.1323158 – volume: 5 start-page: e624 year: 2017 ident: B38 article-title: Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study publication-title: Lancet Global Health doi: 10.1016/S2214-109X(17)30142-0 – volume: 75 start-page: 547 year: 2021 ident: B81 article-title: Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990–2019 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2021.04.035 – start-page: 51 year: 2019 ident: B31 article-title: “Chronic hepatitis,” publication-title: Diagnosis of Liver Disease doi: 10.1007/978-981-13-6806-6_5 – volume: 5 start-page: e992 year: 2017 ident: B63 article-title: Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(17)30298-X – volume: 16 start-page: 5 year: 2006 ident: B42 article-title: Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis publication-title: Rev. Med. Virol. doi: 10.1002/rmv.482 – volume: 25 start-page: 88 year: 2018 ident: B83 article-title: The epidemiology of hepatitis B virus infection in women of reproductive age in highly endemic areas in China publication-title: J. Viral Hepat. doi: 10.1111/jvh.12757 – volume: 20 start-page: 19 year: 2014 ident: B34 article-title: A cohesive European policy for hepatitis B vaccination, are we there yet? publication-title: Clin. Microbiol. Infect. doi: 10.1111/1469-0691.12535 – volume: 378 start-page: 73 year: 2011 ident: B24 article-title: Hepatitis delta virus publication-title: Lancet doi: 10.1016/S0140-6736(10)61931-9 – volume: 10 start-page: 24 year: 2013 ident: B3 article-title: Diagnosis of hepatitis E publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/nrgastro.2012.187 – volume: 212 start-page: 176 year: 2015 ident: B43 article-title: Trends in disease and complications of hepatitis A virus infection in the United States, 1999–2011: a new concern for adults publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiu834 – volume: 11 start-page: 1044788 year: 2023 ident: B36 article-title: SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis publication-title: Front. Public Health doi: 10.3389/fpubh.2023.1044788 – volume: 11 start-page: 100186 year: 2020 ident: B7 article-title: Hepatitis E in Sub Saharan Africa – a significant emerging disease publication-title: One Health doi: 10.1016/j.onehlt.2020.100186 – volume: 21 start-page: 284 year: 2023 ident: B46 article-title: Safeguarding mothers and newborns: the urgent need to address hepatitis during pregnancy publication-title: BMC Med. doi: 10.1186/s12916-023-03006-2 – volume: 7 start-page: 796 year: 2022 ident: B60 article-title: Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(22)00124-8 – volume: 4 start-page: a021550 year: 2014 ident: B48 article-title: Hepatitis D virus coinfection and superinfection publication-title: Cold Spring Harb. Perspect. Med. doi: 10.1101/cshperspect.a021550 – volume: 6 start-page: 169 year: 2021 ident: B20 article-title: Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(20)30359-9 – volume: 72 start-page: 2354 year: 2023 ident: B41 article-title: Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people publication-title: Gut doi: 10.1136/gutjnl-2023-330691 – volume: 10 start-page: e455 year: 2022 ident: B49 article-title: Prevention of mother-to-child transmission of hepatitis B: birth-dose vaccination is not enough publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(22)00046-8 – volume: 17 start-page: 618 year: 2020 ident: B54 article-title: The evolution and clinical impact of hepatitis B virus genome diversity publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-020-0296-6 – volume: 12 start-page: e1288 year: 2024 ident: B80 article-title: Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(24)00192-X – volume: 5 start-page: a021410 year: 2015 ident: B44 article-title: Hepatitis B virus epidemiology publication-title: Cold Spring Harb. Perspect. Med. doi: 10.1101/cshperspect.a021410 – volume: 28 start-page: 101 year: 2006 ident: B77 article-title: Hepatitis A in the era of vaccination publication-title: Epidemiol. Rev. doi: 10.1093/epirev/mxj012 – volume: 105 start-page: 377 year: 2021 ident: B12 article-title: Prevalence and genotype distribution of hepatitis C virus in Mongolia: systematic review and meta-analysis publication-title: Int. J. Infect. Dis. doi: 10.1016/j.ijid.2021.02.040 – volume: 11 start-page: e659 year: 2023 ident: B18 article-title: Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(23)00057-8 – volume: 10 start-page: 225 year: 2018 ident: B28 article-title: Hiding in plain sight? It's time to investigate other possible transmission routes for hepatitis E virus (HEV) in developed countries publication-title: Food Environ. Virol. doi: 10.1007/s12560-018-9342-8 – volume: 6 start-page: 150 year: 2021 ident: B27 article-title: Labour pains: eliminating HCV in women and children publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(20)30373-3 – volume: 11 start-page: 908 year: 2015 ident: B35 article-title: The development of a recombinant hepatitis E vaccine HEV 239 publication-title: Hum. Vaccin. Immunother. doi: 10.1080/21645515.2015.1008870 – volume: 39 start-page: B55 year: 2021 ident: B71 article-title: Monitoring progress of maternal and neonatal immunization in Latin America and the Caribbean publication-title: Vaccine doi: 10.1016/j.vaccine.2020.12.043 – volume: 33 start-page: 1943 year: 2021 ident: B75 article-title: Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease publication-title: Cell Metabolism doi: 10.1016/j.cmet.2021.08.005 – volume: 66 start-page: 102327 year: 2023 ident: B2 article-title: Hepatitis C infection seroprevalence in pregnant women worldwide: a systematic review and meta-analysis publication-title: eClinicalMedicine doi: 10.1016/j.eclinm.2023.102327 – volume: 18 start-page: 117 year: 2021 ident: B66 article-title: Viral hepatitis and pregnancy publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-020-00361-w – volume: 74 start-page: 734 year: 2021 ident: B30 article-title: Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy publication-title: J. Hepatol. doi: 10.1016/j.jhep.2020.11.027 – volume: 396 start-page: 1160 year: 2020 ident: B74 article-title: Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 publication-title: Lancet doi: 10.1016/S0140-6736(20)30977-6 – volume-title: Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries year: 2024 ident: B78 – volume: 28 start-page: 2200738 year: 2023 ident: B9 article-title: Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review publication-title: Eurosurveillance doi: 10.2807/1560-7917.ES.2023.28.30.2200738 – volume: 11 start-page: e0153804 year: 2016 ident: B76 article-title: Changing epidemiological characteristics of hepatitis A in Zhejiang Province, China: increased susceptibility in adults publication-title: PLoS ONE doi: 10.1371/journal.pone.0153804 – volume: 9 start-page: 2090 year: 2019 ident: B10 article-title: The epidemiology of hepatitis C virus in Central Asia: systematic review, meta-analyses, and meta-regression analyses publication-title: Sci. Rep. doi: 10.1038/s41598-019-38853-8 – volume: 57 start-page: 26 year: 2018 ident: B37 article-title: Novel HBV recombinants between genotypes B and C in 3′-terminal reverse transcriptase (RT) sequences are associated with enhanced viral DNA load, higher RT point mutation rates and place of birth among Chinese patients publication-title: Infect. Genet. Evol. doi: 10.1016/j.meegid.2017.10.023 – volume: 55 start-page: 988 year: 2012 ident: B52 article-title: The global burden of hepatitis E virus genotypes 1 and 2 in 2005 publication-title: Hepatology doi: 10.1002/hep.25505 – volume: 61 start-page: S45 year: 2014 ident: B22 article-title: Global epidemiology and genotype distribution of the hepatitis C virus infection publication-title: J. Hepatol. doi: 10.1016/j.jhep.2014.07.027 – volume: 13 start-page: 239 year: 2016 ident: B53 article-title: Global strategies are required to cure and eliminate HBV infection publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/nrgastro.2016.7 – volume: 151 start-page: e50 year: 2023 ident: B8 article-title: Characteristics, treatment and care of pregnant women living with hepatitis B in England: findings from a national audit publication-title: Epidemiol. Infect. doi: 10.1017/S0950268823000225 – volume: 70 start-page: 674 year: 2019 ident: B40 article-title: The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention publication-title: J. Hepatol. doi: 10.1016/j.jhep.2018.12.001 – volume: 27 start-page: 53 year: 2019 ident: B58 article-title: Hepatitis A in Switzerland: an analysis of 29 years of surveillance data and contemporary challenges publication-title: Travel Med. Infect. Dis. doi: 10.1016/j.tmaid.2018.07.012 – volume: 226 start-page: 335 year: 2022 ident: B19 article-title: Treatment and prevention of viral hepatitis in pregnancy publication-title: Am. J. Obstet. Gynecol. doi: 10.1016/j.ajog.2021.09.002 – volume: 6 start-page: 1 year: 2017 ident: B62 article-title: Clinical characteristics and molecular epidemiology of hepatitis E in Shenzhen, China: a shift toward foodborne transmission of hepatitis E virus infection publication-title: Emer. Micr. Infect. doi: 10.1038/emi.2017.107 – volume: 56 start-page: 368 year: 2013 ident: B13 article-title: Hepatitis A virus infection during pregnancy in Korea: hepatitis A infection on pregnant women publication-title: Obstet. Gynecol. Sci. doi: 10.5468/ogs.2013.56.6.368 – volume: 9 start-page: ofac492 year: 2022 ident: B50 article-title: 1240. Hepatitis A in Latin America and the Caribbean: a systematic literature review on endemicity patterns and immunization programs publication-title: Open Forum Infect. Dis. doi: 10.1093/ofid/ofac492.1071 – volume: 8 start-page: e869 year: 2020 ident: B17 article-title: Strategies to increase timely uptake of hepatitis B vaccine birth dose publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(20)30257-6 – volume: 382 start-page: 1166 year: 2020 ident: B73 article-title: Screening and treatment program to eliminate hepatitis C in Egypt publication-title: New Engl. J. Med. doi: 10.1056/NEJMsr1912628 – volume: 18 start-page: 917 year: 2024 ident: B79 article-title: Global burden and trends of acute viral hepatitis among children and adolescents from 1990 to 2019: a systematic analysis of the Global Burden of Disease Study 2019 publication-title: Hepatol. Int. doi: 10.1007/s12072-024-10640-2 – volume: 12 start-page: e1758 year: 2024 ident: B45 article-title: Hepatitis E vaccination: continued benefit for pregnant women in vulnerable settings publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(24)00290-0 – volume: 10 start-page: 854 year: 2016 ident: B69 article-title: Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia publication-title: Hepatol. Int. doi: 10.1007/s12072-016-9745-2 – volume: 72 start-page: 658 year: 2020 ident: B61 article-title: An educate, test and treat model toward elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages publication-title: J. Hepatol. doi: 10.1016/j.jhep.2019.11.004 – volume: 8 start-page: 1132 year: 2012 ident: B72 article-title: Hepatitis A vaccine should receive priority in National Immunization Schedule in India publication-title: Hum. Vaccin. Immunother. doi: 10.4161/hv.20475 – volume: 15 start-page: 1068 year: 2021 ident: B11 article-title: The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention publication-title: Hepatol. Int. doi: 10.1007/s12072-021-10232-4 – volume: 29 start-page: 9303 year: 2011 ident: B23 article-title: Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark publication-title: Vaccine doi: 10.1016/j.vaccine.2011.10.028 – volume: 2 start-page: 1306 year: 2018 ident: B29 article-title: Evaluating women's preferences for hepatitis C treatment during pregnancy publication-title: Hepatol. Commun. doi: 10.1002/hep4.1264 – volume: 21 start-page: 531 year: 2024 ident: B47 article-title: Mother-to-child transmission of hepatitis B: current status and the road forward publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-024-00956-7 – volume: 67 start-page: 370 year: 2017 ident: B32 article-title: EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection publication-title: J. Hepatol. doi: 10.1016/j.jhep.2017.03.021 – volume: 14 start-page: 212 year: 2020 ident: B5 article-title: Regional epidemiology, burden, and management of hepatitis B virus in the middle east publication-title: Clin. Liver. Dis. doi: 10.1002/cld.887 – volume: 28 start-page: 6653 year: 2010 ident: B26 article-title: Hepatitis A virus seroprevalence by age and world region, 1990 and 2005 publication-title: Vaccine doi: 10.1016/j.vaccine.2010.08.037 – year: 2015 ident: B4 article-title: Hepatitis A: epidemiology in resource-poor countries publication-title: Curr. Opin. Infect. Dis. doi: 10.1097/QCO.0000000000000188 – year: 2023 ident: B1 article-title: Viral hepatitis in pregnancy: ACOG clinical practice guideline No. 6 publication-title: Obstet. Gynecol. doi: 10.1097/AOG.0000000000005300 |
| SSID | ssj0000402000 |
| Score | 2.403041 |
| Snippet | The burden and trends of viral hepatitis in women of childbearing age (WCBA) are rarely quantified. This study aimed to assess the global, regional, and... BackgroundThe burden and trends of viral hepatitis in women of childbearing age (WCBA) are rarely quantified. This study aimed to assess the global, regional,... |
| SourceID | doaj proquest pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database |
| StartPage | 1553129 |
| SubjectTerms | age-standardized rate estimated annual percentage change Global Burden of Disease viral hepatitis women of childbearing age |
| Title | Global burden and trends of viral hepatitis among women of childbearing age from 1990 to 2021 |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40061861 https://www.proquest.com/docview/3175685413 https://doaj.org/article/f9a594e0629b4fa5ab038e2880577bfe |
| Volume | 16 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA6yIHgR364vIniTatMmTXJUcV0EPbmwFwlJm-CCdMXtHvz3zqTddS_ixUsPbaHpN9N839B5EHKR50FUWa4TIZROuNDwSVXKJk5irxRX-VRhvfPTczEc8cexGK-M-sKcsLY9cAvcddBWaO7TItOOByusS3PlM3A7IaULHndf4LyVYCruwRgWpWlbJQNRmAYzTUoH8WAmrnBUDoua8oeJYsP-31VmZJvBFtnsZCK9aZe3TdZ8vUPW28GRX7vktW3VT10sQqC2rmgTk1vpNFBM232nbx5zpZvJjMZ5QjS2WsDLsXzbgYMDaVHYTShWmFAGfEGbKYWlsz0yGty_3A2TblBCUmaaN0lVlEDTgWswiLLKljxk0gJVB1_KYFmwurSVckXuZSggxhFpBUIkdyGXQoII2ye9elr7Q0IVS3XmLMPWZxCZcAS98MxaCZFXpXSfXC5AMx9tPwwDcQRCbCLEBiE2HcR9cou4Lu_EXtbxBFjYdBY2f1m4T84XVjHg-_hDw9Z-Op8Z1D6FEsDDfXLQmmv5KI7iTBXs6D-WcEw28LViKTs7Ib3mc-5PQYw07iz6HRwfxuwbKOzZ8g |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+burden+and+trends+of+viral+hepatitis+among+women+of+childbearing+age+from+1990+to+2021&rft.jtitle=Frontiers+in+microbiology&rft.au=Shaojie+Yang&rft.au=Lin+Zhong&rft.au=Lu+Huang&rft.au=Shengyuan+Lin&rft.date=2025-02-21&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-302X&rft.volume=16&rft_id=info:doi/10.3389%2Ffmicb.2025.1553129&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_f9a594e0629b4fa5ab038e2880577bfe |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-302X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-302X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-302X&client=summon |